Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease.
about
Predicted heart rate effect of inhaled PF-00610355, a long acting β-adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease.Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease.Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients treated with inhaled corticosteroids.Dissociated Agonist of Glucocorticoid Receptor or Prednisone for Active Rheumatoid Arthritis: Effects on P1NP and Osteocalcin PharmacodynamicsA model-based longitudinal meta-analysis of FEV1 in randomized COPD trials.Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators.
P2860
Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Longitudinal FEV1 dose-respons ...... obstructive pulmonary disease.
@en
Longitudinal FEV1 dose-respons ...... obstructive pulmonary disease.
@nl
type
label
Longitudinal FEV1 dose-respons ...... obstructive pulmonary disease.
@en
Longitudinal FEV1 dose-respons ...... obstructive pulmonary disease.
@nl
prefLabel
Longitudinal FEV1 dose-respons ...... obstructive pulmonary disease.
@en
Longitudinal FEV1 dose-respons ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Longitudinal FEV1 dose-respons ...... obstructive pulmonary disease
@en
P2093
Jace C Nielsen
Jakob Ribbing
Matthew M Hutmacher
Steven W Martin
P2860
P2888
P304
P356
10.1007/S10928-012-9274-0
P50
P577
2012-09-23T00:00:00Z